世界の癌治療用ジェネリック医薬品市場...市場調査レポートについてご紹介

【英文タイトル】Global Cancer Generics Market Outlook 2018

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Analyst View
2. Research Methodology
3. Global Cancer Drugs Market Outlook 2018
3.1 Cancer Incidences
3.2 Cancer Drug Market
4. Global Cancer Generics Market Analysis 2018
5. Cancer Generic Drugs Industry
5.1 Oral Generic Drugs
5.1.1 Arimidex (Anastrozole)
5.1.2 Femara (Letrozole)
5.1.3 Hycamtin (Topotecan)
5.1.4 Stivarga (Regorafenib)
5.1.5 Tarceva (Erlotinib)
5.1.6 Xalkori (Crizotinib)
5.1.7 Xeloda (Capecitabine)
5.2 Generic Injectables
5.2.1 Camptosar (Irinotecan Hydrochloride)
5.2.2 Eloxatin (Oxaliplatin)
5.2.3 Gemzar (Gemcitabine Hydrochloride)
5.2.4 Navelbine (Vinorelbine Tartrate)
5.2.5 Platinol (Cisplatin)
5.2.6 Taxol (Paclitaxel)
5.2.7 Taxotere (Docetaxel)
6. Cancer Generics Market: Major Indications
6.1 Lung Cancer
6.1.1 Incidence Outlook
6.1.2 Commercialized Drugs
6.2 Breast Cancer
6.2.1 Incidence Outlook
6.2.2 Commercialized Drugs
6.3 Colorectal Cancer
6.3.1 Incidence Outlook
6.3.2 Commercialized Drugs
6.4 Stomach Cancer
6.4.1 Incidence Outlook
6.4.2 Commercialized Drugs
6.5 Prostate Cancer
6.5.1 Incidence Outlook
6.5.2 Commercialized Drugs
7. Market Dynamics
7.1 Indian Generic Cancer Drug Introduced in the US Market
7.2 Launch of Generic Drugs for Oncology
7.3 Increasing Cancer Burden Paving Way for Generics
7.4 Patent Expiry of Blockbuster Oncology Drugs
7.5 Strategic Collaborations
8. Key Players
8.1 Fresenius Kabi AG
8.1.1 Business Overview
8.1.2 Key Financials
8.1.3 Strategic Developments
8.2 Actavis Plc.
8.2.1 Business Overview
8.2.2 Key Financials
8.2.3 Strategic Developments
8.3 Hospira
8.3.1 Business Overview
8.3.2 Key Financials
8.3.3 Strategic Developments
8.4 Teva Pharmaceutical Industries Ltd.
8.4.1 Business Overview
8.4.2 Key Financials
8.4.3 Strategic Developments
8.5 Mylan
8.5.1 Business Overview
8.5.2 Key Financials
8.5.3 Strategic Developments
8.6 Sun Pharmaceuticals
8.6.1 Business Overview
8.6.2 Key Financials
8.6.3 Strategic Developments

List of Figures:

Figure 3-1: Global – Number of New Cancer Cases (Million), 2012 & 2025
Figure 3-2: Global – Cancer Incidences by Gender (Million), 2012
Figure 3-3: Global – Cancer Drugs Market (Billion US$), 2008-2013
Figure 3-4: Global – Cancer Drugs Market (Billion US$), 2014-2018
Figure 3-5: Cancer Drugs Market Share by Geography (%), 2013
Figure 3-6: Cancer Drugs Market Share by Geography (%), 2018
Figure 3-7: Global – Cancer Treatment Modalities Revenue Share (%), 2013
Figure 4-1: Global – Cancer Generics Market (Billion US$), 2013-2018
Figure 6-1: Global – Number of New Lung Cancer Cases (Million), 2012 & 2020
Figure 6-2: Global – Forecast for New Lung Cancer Cases by Region (%), 2020
Figure 6-3: Global – Number of New Breast Cancer Cases (Million), 2012 & 2020
Figure 6-4: Global – Forecast for New Breast Cancer Cases by Region (%), 2020
Figure 6-5: Global – Number of New Colorectal Cancer Cases (Million), 2012 & 2020
Figure 6-6: Global – Forecast for New Colorectal Cancer Cases by Region (%), 2020
Figure 6-7: Global – Number of New Stomach Cancer Cases (Million), 2012 & 2020
Figure 6-8: Global – Forecast for New Stomach Cancer Cases by Region (%), 2020
Figure 6-9: Global – Number of New Prostate Cancer Cases (Million), 2012 & 2020
Figure 6-10: Global – Forecast for New Prostate Cancer Cases by Region (%), 2020
Figure 8-1: Fresenius Kabi – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-2: Fresenius Kabi – Revenue Share by Region (%), 2013
Figure 8-3: Fresenius Kabi – Revenue Share by Business Segment (%), 2013
Figure 8-4: Actavis – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-5: Actavis – Revenue Share by Region (%), 2013
Figure 8-6: Actavis – Revenue Share by Business Segment (%), 2013
Figure 8-7: Hospira – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-8: Hospira – Revenue Share by Region (%), 2013
Figure 8-9: Hospira – Revenue Share by Business Segment (%), 2013
Figure 8-10: Teva – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-11: Teva – Revenue Share by Region (%), 2013
Figure 8-12: Hospira – Revenue Share by Business Segment (%), 2013
Figure 8-13: Mylan – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-14: Mylan – Revenue Share by Region (%), 2013
Figure 8-15: Mylan – Revenue Share by Business Segment (%), 2013
Figure 8-16: Sun Pharma – Sales & Net Income (Billion US$), 2012-13/ 2013-14
Figure 8-17: Sun Pharma – Revenue Share by Business Segment (%), 2013-14

List of Tables:

Table 3-1: Most Prevalent Types of Cancer
Table 3-2: Top 10 Countries with Highest Cancer Prevalence Rates
Table 5-1: List of Companies Dealing in Generic Arimidex
Table 5-2: Cost Comparison of Generics and Branded Arimidex (Anastrozole)
Table 5-3: List of Companies Dealing in Generic Femara
Table 5-4: Cost Comparison of Generics and Branded Femara (Letrozole)
Table 5-5: List of Companies Dealing in Generic Hycamtin
Table 5-6: List of Companies Dealing in Generic Xeloda
Table 5-7: Cost Comparison of Generics and Branded Xeloda (Capecitabine)
Table 5-8: List of Companies Dealing in Generic Camptosar
Table 5-9: Cost Comparison of Generics and Branded Camptosar (Irinotecan Hydrochloride)
Table 5-10: List of Companies Dealing in Generic Gemzar (Gemcitabine Hydrochloride)
Table 5-11: Cost Comparison of Generics and Branded Gemzar (Gemcitabine Hydrochloride)
Table 5-12: List of Companies Dealing in Generic Navelbine (Vinorelbine)
Table 5-13: Cost Comparison of Generics and Branded Navelbine (Vinorelbine)
Table 5-14: List of Companies Dealing in Generic Platinol (Cisplatin)
Table 5-15: List of Companies Dealing in Generic Taxol (Paclitaxel)
Table 5-16: Cost Comparison of Generics and Branded Taxol (Paclitaxel)
Table 5-17: List of Companies Dealing in Generic Taxotere (Docetaxel)
Table 5-18: Cost Comparison of Generics and Branded Taxotere (Docetaxel)
Table 6-1: Top 10 Countries by Lung Cancer Incidences (2012)
Table 6-2: Global – Key Lung Cancer Drugs and Patent Expiry Status
Table 6-3: Top 10 Countries by Breast Cancer Incidences (2012)
Table 6-4: Global – Key Breast Cancer Drugs and Patent Expiry Status
Table 6-5: Top 10 Countries by Colorectal Cancer Incidences (2012)
Table 6-6: Global – Key Colorectal Cancer Drugs and Patent Expiry Status
Table 6-7: Top 10 Countries by Stomach Cancer Incidences (2012)
Table 6-8: Global – Key Stomach Cancer Drugs and Patent Expiry Status
Table 6-9: Top 10 Countries by Prostate Cancer Incidences (2012)
Table 6-10: Global – Key Prostate Cancer Drugs and Patent Expiry Status
Table 7-1: Global – Key Cancer Drugs and Patent Expiry Status
Table 8-1: Fresnius Kabi Pharmaceuticals – Key Cancer Generic Drugs
Table 8-2: Actavis – Key Cancer Generic Drugs
Table 8-3: Hospira – Key Cancer Generic Products
Table 8-4: Teva Pharmaceuticals – Key Cancer Generic Drugs
Table 8-5: Mylan – Key Cancer Generic Drugs
Table 8-6: Sun Pharmaceuticals – Key Cancer Generic Drugs


【レポート販売概要】

■ タイトル:世界の癌治療用ジェネリック医薬品市場
■ 英文:Global Cancer Generics Market Outlook 2018
■ 発行日:2014年8月
■ 調査会社:RNCOS
■ 商品コード:RNCS4087
■ 調査対象地域:グローバル
  • 太陽光発電とカーボンナノチューブ
    Carbon nanotubes are allotropes of carbon with a cylindrical nanostructure. Nanotubes have been constructed with length-to-diameter ratio of up to 132,000,000:1, which is significantly larger than any other material. These cylindrical carbon molecules have novel properties that make them potentially useful in many applications in nanotechnology, electronics, optics and other fields of materials sc …
  • 世界の軍用レーダ市場動向2013-2023:競合環境及び戦略的インサイト
    The report provides a detailed analysis of the competitive landscape of the Military Radar market. It provides an overview of key Military Radar companies catering to the Military Radar sector, together with insights such as key alliances, strategic initiatives and a brief financial analysis.
  • クロマトグラフィーの世界市場:液体クロマトグラフィー、ガスクロマトグラフィー、イオン交換クロマトグラフィー
    About Chromatography Chromatography is a technique in which a mixture is passed into solution or suspension through a path in which the components move at different rates. It is used to separate the components of a liquid with great accuracy. There are several types of separation techniques such as liquid chromatography, gas chromatography, and electrophoresis. The technique used depends on the so …
  • 耐切創性手袋の世界市場
    ABSTRACTAbout Cut Resistant Gloves A glove is a personal protective equipment (PPE) that covers the whole hand. It is used for protection from heat, cold, chemical reactions, and injuries. Gloves are used for personal as well as industrial applications to protect the wearer from cuts, abrasions, heat, impacts, and vibrations. Cut-resistant gloves are designed to protect worker's hands against inju …
  • フリードライヒ運動失調症(Friedreich Ataxia):世界の治験レビュー(2015年上半期版)
    Friedreich Ataxia Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Friedreich Ataxia Global Clinical Trials Review, H1, 2015" provides data on the Friedreich Ataxia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Friedreich Ataxia. It includes an overview of the trial numbers and their recruitment s …
  • 2014年戦略提言:イタリアのHIV/AIDS診断・検査市場
    Complete report $2,300.  DataPack (test volumes, sales forecasts, supplier shares) $1,500.Summary This report presents detailed analyses of the AIDS diagnostics market in Italy.  The report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments:     - Hospitals   …
  • 感染症診断・検査製品の世界市場:感染症検査試薬、検査キット、診断機器、アナライザー
    Increasing Prevalence of Deadly Infectious Disease and Need For Highly Specific and Sensitive Technologies for Rapid Diagnosis to Drive Growth of the IDD Market The global IDD market report is segmented by product, application, technology, end user, and region. The immunodiagnostics and polymerase chain reaction technology segments accounted for the lion’s share of the global IDD market by technol …
  • 蛍光増白剤の世界市場予測(~2020)
    The global optical brighteners market is estimated to reach USD 1.05 Billion by 2020, registering a CAGR of 9.6% between 2015 and 2020. The market is driven by increasing demand for optical brighteners in emerging markets and high demand from the paper, fabrics, detergents & soap application segments. Optical brighteners have unique properties, such as high fluorescence, light fastness, heat resis …
  • Respiratory Diseases in Spain 2014: Market Outlook and Emerging Opportunities
    About This ReportThis new 281-page report from Venture Planning Group presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.   …
  • ファンタジー・スポーツの世界市場2015-2019
    About Fantasy Sports A fantasy sport, also known as rotisserie or owner simulation or roto, is an online game that allows end-users to own a fantasy sport team along with real-life professional players. The performance of the fantasy sport team depends on the real-life performance of players. End-users participate in various fantasy sports events after paying league fees. The winners of these spor …
  • 医療ITソリューションの世界市場:EHR、RIS、PACS、VNA、CPOE、mHealth、遠隔医療、分析、SCM、RCM、CRM、請求管理、不正管理
    The healthcare industry is undergoing a major transformation due to the challenge of providing more cost-effective personalized care. The push towards predictable outcomes and higher quality of care is leading to convergence of information technologies. Healthcare IT systems are emerging as powerful tools to create and maintain electronic health records (EHRs) for maintaining the workflows in the …
  • 世界主要国における非小細胞肺癌(NSCLC)治療薬市場
    Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line Summary Non-Small Cell Lung Cancer (NSCLC) is the second most common cancer globally, and the most common cause of cancer-related mortality. Such a poor outlook, particularly for patients with advanced disease, has created a pressing n …
  • 世界の受動光ネットワーク(PON)装置市場動向(2012-2016)
    TechNavio's analysts forecast the Global Passive Optical Network (PON) Equipment market to grow at a CAGR of 23.14 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing growth of PON equipment in China. The Global PON Equipment market has also been witnessing the development of ultra-high capacity optical networks. However, the declining ave …
  • 酸性度(Acidity):世界の治験レビュー(2015年上半期版)
    Acidity Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Acidity Global Clinical Trials Review, H1, 2015" provides data on the Acidity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acidity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conductio …
  • セーフティライトカーテンの世界市場予測(~2025年)
    “Safety light curtain market to grow at a CAGR of 6.5% from 2019 to 2025” The safety light curtain market is expected to grow from USD 1.1 billion by 2019 to USD 1.6 billion by 2025 at a CAGR of 6.5% from 2019 to 2025. A few key factors driving the growth of this market include the rise in Industry 4.0; the growing use of robotics in the packaging industry; and mandatory safety regulations across …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。